C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 317/72 (2006.01) A61K 31/496 (2006.01) A61K 31/5377 (2006.01) A61P 3/04 (2006.01)
Patent
CA 2553970
The present invention relates to compounds of formula (I) wherein R1, R2, R3, R4, R5 and X are as defined in the description and claims, and pharmaceutically acceptable salts thereof, for use as therapeutically active substances. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB 1 receptors.
La présente invention a trait à des composés de formule (I), dans laquelle R1, R2, R3, R4, R5 et X sont tels que définis dans la descriptions et les revendications, et leurs sels pharmaceutiquement acceptables, destinés à être utilisés en tant que substances d'activité thérapeutique. Les composés sont utiles pour le traitement et/ou la prophylaxie de maladies qui sont associées à la modulation des récepteurs CB1.
Plancher Jean-Marc
Taylor Sven
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Spiro-benzodioxoles and their use as cb1 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spiro-benzodioxoles and their use as cb1 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiro-benzodioxoles and their use as cb1 antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1429732